Upgrade to SI Premium - Free Trial

Cowen Downgrades Myriad Genetics (MYGN) to Market Perform

August 14, 2013 7:36 AM
Cowen downgraded Myriad Genetics (NASDAQ: MYGN) from Outperform to Market ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Downgrades Hot Downgrades

Next Articles